Ulcerative Colitis (UC) Recruiting Phase 3 Trials for Vedolizumab (DB09033)

Also known as: UC - Ulcerative Colitis / Colitis, Ulcerative (UC) / Ulcerative Colitis / Colitis, Ulcerative / Colitis,Ulcerative / Colitis Ulcerative / Proctocolitis, idiopathic / Idiopathic proctocolitis / UC / Ulcerative colitis, unspecified

IndicationStatusPhase
DBCOND0052192 (Ulcerative Colitis (UC))Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02620046Vedolizumab Subcutaneous Long-Term Open-Label Extension StudyTreatment